nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—UGT1A9—Mycophenolic acid—systemic scleroderma	0.232	0.296	CbGbCtD
Tapentadol—UGT2B7—Mycophenolic acid—systemic scleroderma	0.219	0.28	CbGbCtD
Tapentadol—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.13	0.165	CbGbCtD
Tapentadol—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.123	0.156	CbGbCtD
Tapentadol—CYP2C9—Leflunomide—systemic scleroderma	0.035	0.0447	CbGbCtD
Tapentadol—CYP2D6—Captopril—systemic scleroderma	0.0251	0.0321	CbGbCtD
Tapentadol—CYP2C19—Prednisone—systemic scleroderma	0.0208	0.0265	CbGbCtD
Tapentadol—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0128	0.402	CbGeAlD
Tapentadol—CYP2C9—cardial valve—systemic scleroderma	0.011	0.344	CbGeAlD
Tapentadol—UGT1A9—digestive system—systemic scleroderma	0.00165	0.0517	CbGeAlD
Tapentadol—UGT2B7—digestive system—systemic scleroderma	0.00133	0.0417	CbGeAlD
Tapentadol—HTR3A—digestive system—systemic scleroderma	0.000971	0.0304	CbGeAlD
Tapentadol—HTR3A—lung—systemic scleroderma	0.000811	0.0254	CbGeAlD
Tapentadol—SLC6A4—digestive system—systemic scleroderma	0.000741	0.0232	CbGeAlD
Tapentadol—SLC6A4—lung—systemic scleroderma	0.000619	0.0194	CbGeAlD
Tapentadol—CYP2C19—digestive system—systemic scleroderma	0.000614	0.0192	CbGeAlD
Tapentadol—SLC6A2—lung—systemic scleroderma	0.000545	0.0171	CbGeAlD
Tapentadol—CYP2C9—digestive system—systemic scleroderma	0.000476	0.0149	CbGeAlD
Tapentadol—CYP2D6—digestive system—systemic scleroderma	0.000357	0.0112	CbGeAlD
Tapentadol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000296	0.00161	CcSEcCtD
Tapentadol—Tension—Mycophenolate mofetil—systemic scleroderma	0.000295	0.0016	CcSEcCtD
Tapentadol—Insomnia—Leflunomide—systemic scleroderma	0.000294	0.0016	CcSEcCtD
Tapentadol—Paraesthesia—Leflunomide—systemic scleroderma	0.000292	0.00159	CcSEcCtD
Tapentadol—Arthralgia—Lisinopril—systemic scleroderma	0.000292	0.00159	CcSEcCtD
Tapentadol—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000292	0.00159	CcSEcCtD
Tapentadol—Anxiety—Lisinopril—systemic scleroderma	0.000291	0.00158	CcSEcCtD
Tapentadol—Dyspnoea—Leflunomide—systemic scleroderma	0.00029	0.00158	CcSEcCtD
Tapentadol—Hypotension—Mycophenolic acid—systemic scleroderma	0.00029	0.00158	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00029	0.00158	CcSEcCtD
Tapentadol—Lethargy—Methotrexate—systemic scleroderma	0.000288	0.00157	CcSEcCtD
Tapentadol—Dyspepsia—Leflunomide—systemic scleroderma	0.000286	0.00156	CcSEcCtD
Tapentadol—Vomiting—Mometasone—systemic scleroderma	0.000286	0.00155	CcSEcCtD
Tapentadol—Dry mouth—Lisinopril—systemic scleroderma	0.000285	0.00155	CcSEcCtD
Tapentadol—Feeling abnormal—Azathioprine—systemic scleroderma	0.000284	0.00154	CcSEcCtD
Tapentadol—Rash—Mometasone—systemic scleroderma	0.000283	0.00154	CcSEcCtD
Tapentadol—Asthenia—Captopril—systemic scleroderma	0.000283	0.00154	CcSEcCtD
Tapentadol—Dermatitis—Mometasone—systemic scleroderma	0.000283	0.00154	CcSEcCtD
Tapentadol—Decreased appetite—Leflunomide—systemic scleroderma	0.000283	0.00154	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000283	0.00154	CcSEcCtD
Tapentadol—Osteoarthritis—Methotrexate—systemic scleroderma	0.000282	0.00154	CcSEcCtD
Tapentadol—Confusional state—Lisinopril—systemic scleroderma	0.000282	0.00153	CcSEcCtD
Tapentadol—Headache—Mometasone—systemic scleroderma	0.000282	0.00153	CcSEcCtD
Tapentadol—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000281	0.00153	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000281	0.00153	CcSEcCtD
Tapentadol—Insomnia—Mycophenolic acid—systemic scleroderma	0.000281	0.00153	CcSEcCtD
Tapentadol—Fatigue—Leflunomide—systemic scleroderma	0.000281	0.00153	CcSEcCtD
Tapentadol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00028	0.00152	CcSEcCtD
Tapentadol—Oedema—Lisinopril—systemic scleroderma	0.00028	0.00152	CcSEcCtD
Tapentadol—Pruritus—Captopril—systemic scleroderma	0.000279	0.00152	CcSEcCtD
Tapentadol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000279	0.00152	CcSEcCtD
Tapentadol—Constipation—Leflunomide—systemic scleroderma	0.000278	0.00151	CcSEcCtD
Tapentadol—Infection—Lisinopril—systemic scleroderma	0.000278	0.00151	CcSEcCtD
Tapentadol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000277	0.00151	CcSEcCtD
Tapentadol—Somnolence—Mycophenolic acid—systemic scleroderma	0.000276	0.0015	CcSEcCtD
Tapentadol—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000276	0.0015	CcSEcCtD
Tapentadol—Shock—Lisinopril—systemic scleroderma	0.000275	0.0015	CcSEcCtD
Tapentadol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00149	CcSEcCtD
Tapentadol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000273	0.00149	CcSEcCtD
Tapentadol—Tachycardia—Lisinopril—systemic scleroderma	0.000273	0.00148	CcSEcCtD
Tapentadol—Skin disorder—Lisinopril—systemic scleroderma	0.000272	0.00148	CcSEcCtD
Tapentadol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00027	0.00147	CcSEcCtD
Tapentadol—Diarrhoea—Captopril—systemic scleroderma	0.00027	0.00147	CcSEcCtD
Tapentadol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00027	0.00147	CcSEcCtD
Tapentadol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00147	CcSEcCtD
Tapentadol—Irritability—Methotrexate—systemic scleroderma	0.000269	0.00147	CcSEcCtD
Tapentadol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00146	CcSEcCtD
Tapentadol—Erectile dysfunction—Prednisone—systemic scleroderma	0.000269	0.00146	CcSEcCtD
Tapentadol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000268	0.00146	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000268	0.00146	CcSEcCtD
Tapentadol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000268	0.00146	CcSEcCtD
Tapentadol—Nausea—Mometasone—systemic scleroderma	0.000267	0.00145	CcSEcCtD
Tapentadol—Ataxia—Methotrexate—systemic scleroderma	0.000265	0.00144	CcSEcCtD
Tapentadol—Constipation—Mycophenolic acid—systemic scleroderma	0.000265	0.00144	CcSEcCtD
Tapentadol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00144	CcSEcCtD
Tapentadol—Weight decreased—Prednisone—systemic scleroderma	0.000264	0.00144	CcSEcCtD
Tapentadol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000264	0.00143	CcSEcCtD
Tapentadol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00142	CcSEcCtD
Tapentadol—Hypotension—Lisinopril—systemic scleroderma	0.000261	0.00142	CcSEcCtD
Tapentadol—Dizziness—Captopril—systemic scleroderma	0.000261	0.00142	CcSEcCtD
Tapentadol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00141	CcSEcCtD
Tapentadol—Depression—Prednisone—systemic scleroderma	0.00026	0.00141	CcSEcCtD
Tapentadol—Urticaria—Leflunomide—systemic scleroderma	0.000258	0.00141	CcSEcCtD
Tapentadol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000256	0.00139	CcSEcCtD
Tapentadol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00139	CcSEcCtD
Tapentadol—Breast disorder—Methotrexate—systemic scleroderma	0.000255	0.00139	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000255	0.00139	CcSEcCtD
Tapentadol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00139	CcSEcCtD
Tapentadol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000254	0.00138	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00138	CcSEcCtD
Tapentadol—Insomnia—Lisinopril—systemic scleroderma	0.000253	0.00138	CcSEcCtD
Tapentadol—Paraesthesia—Lisinopril—systemic scleroderma	0.000251	0.00137	CcSEcCtD
Tapentadol—Vomiting—Captopril—systemic scleroderma	0.000251	0.00137	CcSEcCtD
Tapentadol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00025	0.00136	CcSEcCtD
Tapentadol—Dyspnoea—Lisinopril—systemic scleroderma	0.000249	0.00136	CcSEcCtD
Tapentadol—Rash—Captopril—systemic scleroderma	0.000249	0.00135	CcSEcCtD
Tapentadol—Dermatitis—Captopril—systemic scleroderma	0.000249	0.00135	CcSEcCtD
Tapentadol—Somnolence—Lisinopril—systemic scleroderma	0.000249	0.00135	CcSEcCtD
Tapentadol—Headache—Captopril—systemic scleroderma	0.000247	0.00135	CcSEcCtD
Tapentadol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00134	CcSEcCtD
Tapentadol—Dyspepsia—Lisinopril—systemic scleroderma	0.000246	0.00134	CcSEcCtD
Tapentadol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00133	CcSEcCtD
Tapentadol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00133	CcSEcCtD
Tapentadol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00132	CcSEcCtD
Tapentadol—Decreased appetite—Lisinopril—systemic scleroderma	0.000243	0.00132	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000241	0.00131	CcSEcCtD
Tapentadol—Fatigue—Lisinopril—systemic scleroderma	0.000241	0.00131	CcSEcCtD
Tapentadol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00131	CcSEcCtD
Tapentadol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00131	CcSEcCtD
Tapentadol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00024	0.0013	CcSEcCtD
Tapentadol—Constipation—Lisinopril—systemic scleroderma	0.000239	0.0013	CcSEcCtD
Tapentadol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000239	0.0013	CcSEcCtD
Tapentadol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000238	0.00129	CcSEcCtD
Tapentadol—Bradycardia—Prednisone—systemic scleroderma	0.000238	0.00129	CcSEcCtD
Tapentadol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000237	0.00129	CcSEcCtD
Tapentadol—Diarrhoea—Azathioprine—systemic scleroderma	0.000236	0.00128	CcSEcCtD
Tapentadol—Nausea—Captopril—systemic scleroderma	0.000234	0.00128	CcSEcCtD
Tapentadol—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000234	0.00127	CcSEcCtD
Tapentadol—Asthenia—Leflunomide—systemic scleroderma	0.000233	0.00127	CcSEcCtD
Tapentadol—Hallucination—Prednisone—systemic scleroderma	0.000233	0.00126	CcSEcCtD
Tapentadol—Feeling abnormal—Lisinopril—systemic scleroderma	0.00023	0.00125	CcSEcCtD
Tapentadol—Pruritus—Leflunomide—systemic scleroderma	0.00023	0.00125	CcSEcCtD
Tapentadol—Connective tissue disorder—Prednisone—systemic scleroderma	0.00023	0.00125	CcSEcCtD
Tapentadol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00125	CcSEcCtD
Tapentadol—Dizziness—Azathioprine—systemic scleroderma	0.000228	0.00124	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000227	0.00123	CcSEcCtD
Tapentadol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000225	0.00122	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000223	0.00121	CcSEcCtD
Tapentadol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000223	0.00121	CcSEcCtD
Tapentadol—Diarrhoea—Leflunomide—systemic scleroderma	0.000223	0.00121	CcSEcCtD
Tapentadol—Urticaria—Lisinopril—systemic scleroderma	0.000222	0.00121	CcSEcCtD
Tapentadol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00121	CcSEcCtD
Tapentadol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.0012	CcSEcCtD
Tapentadol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00022	0.00119	CcSEcCtD
Tapentadol—Vomiting—Azathioprine—systemic scleroderma	0.000219	0.00119	CcSEcCtD
Tapentadol—Eye disorder—Prednisone—systemic scleroderma	0.000218	0.00119	CcSEcCtD
Tapentadol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00119	CcSEcCtD
Tapentadol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00118	CcSEcCtD
Tapentadol—Infestation NOS—Methotrexate—systemic scleroderma	0.000218	0.00118	CcSEcCtD
Tapentadol—Infestation—Methotrexate—systemic scleroderma	0.000218	0.00118	CcSEcCtD
Tapentadol—Rash—Azathioprine—systemic scleroderma	0.000217	0.00118	CcSEcCtD
Tapentadol—Dermatitis—Azathioprine—systemic scleroderma	0.000217	0.00118	CcSEcCtD
Tapentadol—Depression—Methotrexate—systemic scleroderma	0.000217	0.00118	CcSEcCtD
Tapentadol—Headache—Azathioprine—systemic scleroderma	0.000216	0.00117	CcSEcCtD
Tapentadol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000216	0.00117	CcSEcCtD
Tapentadol—Dizziness—Leflunomide—systemic scleroderma	0.000215	0.00117	CcSEcCtD
Tapentadol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000213	0.00116	CcSEcCtD
Tapentadol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000212	0.00116	CcSEcCtD
Tapentadol—Angiopathy—Prednisone—systemic scleroderma	0.000212	0.00115	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000211	0.00115	CcSEcCtD
Tapentadol—Immune system disorder—Prednisone—systemic scleroderma	0.000211	0.00115	CcSEcCtD
Tapentadol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00114	CcSEcCtD
Tapentadol—Vomiting—Leflunomide—systemic scleroderma	0.000207	0.00113	CcSEcCtD
Tapentadol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000206	0.00112	CcSEcCtD
Tapentadol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000205	0.00112	CcSEcCtD
Tapentadol—Rash—Leflunomide—systemic scleroderma	0.000205	0.00112	CcSEcCtD
Tapentadol—Dermatitis—Leflunomide—systemic scleroderma	0.000205	0.00111	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—systemic scleroderma	0.000205	0.00111	CcSEcCtD
Tapentadol—Nausea—Azathioprine—systemic scleroderma	0.000205	0.00111	CcSEcCtD
Tapentadol—Headache—Leflunomide—systemic scleroderma	0.000204	0.00111	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—systemic scleroderma	0.000203	0.00111	CcSEcCtD
Tapentadol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000202	0.0011	CcSEcCtD
Tapentadol—Asthenia—Lisinopril—systemic scleroderma	0.000201	0.00109	CcSEcCtD
Tapentadol—Pruritus—Lisinopril—systemic scleroderma	0.000198	0.00108	CcSEcCtD
Tapentadol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000197	0.00107	CcSEcCtD
Tapentadol—Rash—Mycophenolic acid—systemic scleroderma	0.000196	0.00106	CcSEcCtD
Tapentadol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000196	0.00106	CcSEcCtD
Tapentadol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00106	CcSEcCtD
Tapentadol—Headache—Mycophenolic acid—systemic scleroderma	0.000194	0.00106	CcSEcCtD
Tapentadol—Nausea—Leflunomide—systemic scleroderma	0.000193	0.00105	CcSEcCtD
Tapentadol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000193	0.00105	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—systemic scleroderma	0.000192	0.00104	CcSEcCtD
Tapentadol—Urethral disorder—Methotrexate—systemic scleroderma	0.000191	0.00104	CcSEcCtD
Tapentadol—Diarrhoea—Lisinopril—systemic scleroderma	0.000191	0.00104	CcSEcCtD
Tapentadol—Visual impairment—Methotrexate—systemic scleroderma	0.000188	0.00102	CcSEcCtD
Tapentadol—Agitation—Prednisone—systemic scleroderma	0.000187	0.00102	CcSEcCtD
Tapentadol—Angioedema—Prednisone—systemic scleroderma	0.000186	0.00101	CcSEcCtD
Tapentadol—Dizziness—Lisinopril—systemic scleroderma	0.000185	0.00101	CcSEcCtD
Tapentadol—Nausea—Mycophenolic acid—systemic scleroderma	0.000184	0.001	CcSEcCtD
Tapentadol—Vertigo—Prednisone—systemic scleroderma	0.000183	0.000994	CcSEcCtD
Tapentadol—Eye disorder—Methotrexate—systemic scleroderma	0.000183	0.000993	CcSEcCtD
Tapentadol—Syncope—Prednisone—systemic scleroderma	0.000182	0.000992	CcSEcCtD
Tapentadol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000181	0.000986	CcSEcCtD
Tapentadol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000982	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—systemic scleroderma	0.000179	0.000973	CcSEcCtD
Tapentadol—Vomiting—Lisinopril—systemic scleroderma	0.000178	0.000967	CcSEcCtD
Tapentadol—Angiopathy—Methotrexate—systemic scleroderma	0.000177	0.000964	CcSEcCtD
Tapentadol—Immune system disorder—Methotrexate—systemic scleroderma	0.000176	0.00096	CcSEcCtD
Tapentadol—Rash—Lisinopril—systemic scleroderma	0.000176	0.000959	CcSEcCtD
Tapentadol—Convulsion—Prednisone—systemic scleroderma	0.000176	0.000959	CcSEcCtD
Tapentadol—Dermatitis—Lisinopril—systemic scleroderma	0.000176	0.000958	CcSEcCtD
Tapentadol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000176	0.000958	CcSEcCtD
Tapentadol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000956	CcSEcCtD
Tapentadol—Chills—Methotrexate—systemic scleroderma	0.000175	0.000953	CcSEcCtD
Tapentadol—Headache—Lisinopril—systemic scleroderma	0.000175	0.000953	CcSEcCtD
Tapentadol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000943	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—systemic scleroderma	0.000173	0.000942	CcSEcCtD
Tapentadol—Anxiety—Prednisone—systemic scleroderma	0.000173	0.000939	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000172	0.000936	CcSEcCtD
Tapentadol—Mental disorder—Methotrexate—systemic scleroderma	0.000171	0.000931	CcSEcCtD
Tapentadol—Malnutrition—Methotrexate—systemic scleroderma	0.00017	0.000925	CcSEcCtD
Tapentadol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000912	CcSEcCtD
Tapentadol—Nausea—Lisinopril—systemic scleroderma	0.000166	0.000903	CcSEcCtD
Tapentadol—Oedema—Prednisone—systemic scleroderma	0.000166	0.000903	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000166	0.000903	CcSEcCtD
Tapentadol—Infection—Prednisone—systemic scleroderma	0.000165	0.000897	CcSEcCtD
Tapentadol—Shock—Prednisone—systemic scleroderma	0.000163	0.000889	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—systemic scleroderma	0.000163	0.000886	CcSEcCtD
Tapentadol—Tachycardia—Prednisone—systemic scleroderma	0.000162	0.000881	CcSEcCtD
Tapentadol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000881	CcSEcCtD
Tapentadol—Skin disorder—Prednisone—systemic scleroderma	0.000161	0.000877	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000161	0.000873	CcSEcCtD
Tapentadol—Vision blurred—Methotrexate—systemic scleroderma	0.00016	0.000872	CcSEcCtD
Tapentadol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000847	CcSEcCtD
Tapentadol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00084	CcSEcCtD
Tapentadol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000839	CcSEcCtD
Tapentadol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000835	CcSEcCtD
Tapentadol—Vertigo—Methotrexate—systemic scleroderma	0.000153	0.000831	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000151	0.000823	CcSEcCtD
Tapentadol—Insomnia—Prednisone—systemic scleroderma	0.00015	0.000817	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—systemic scleroderma	0.000149	0.000811	CcSEcCtD
Tapentadol—Cough—Methotrexate—systemic scleroderma	0.000148	0.000807	CcSEcCtD
Tapentadol—Convulsion—Methotrexate—systemic scleroderma	0.000147	0.000801	CcSEcCtD
Tapentadol—Dyspepsia—Prednisone—systemic scleroderma	0.000146	0.000795	CcSEcCtD
Tapentadol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000791	CcSEcCtD
Tapentadol—Arthralgia—Methotrexate—systemic scleroderma	0.000145	0.000787	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—systemic scleroderma	0.000144	0.000785	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000144	0.000782	CcSEcCtD
Tapentadol—Fatigue—Prednisone—systemic scleroderma	0.000143	0.000779	CcSEcCtD
Tapentadol—Constipation—Prednisone—systemic scleroderma	0.000142	0.000772	CcSEcCtD
Tapentadol—Confusional state—Methotrexate—systemic scleroderma	0.00014	0.000761	CcSEcCtD
Tapentadol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000139	0.000755	CcSEcCtD
Tapentadol—Infection—Methotrexate—systemic scleroderma	0.000138	0.00075	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisone—systemic scleroderma	0.000137	0.000744	CcSEcCtD
Tapentadol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000136	0.00074	CcSEcCtD
Tapentadol—Skin disorder—Methotrexate—systemic scleroderma	0.000135	0.000733	CcSEcCtD
Tapentadol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000134	0.00073	CcSEcCtD
Tapentadol—Urticaria—Prednisone—systemic scleroderma	0.000132	0.000718	CcSEcCtD
Tapentadol—Hypotension—Methotrexate—systemic scleroderma	0.00013	0.000705	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000126	0.000688	CcSEcCtD
Tapentadol—Insomnia—Methotrexate—systemic scleroderma	0.000126	0.000683	CcSEcCtD
Tapentadol—Paraesthesia—Methotrexate—systemic scleroderma	0.000125	0.000678	CcSEcCtD
Tapentadol—Dyspnoea—Methotrexate—systemic scleroderma	0.000124	0.000673	CcSEcCtD
Tapentadol—Somnolence—Methotrexate—systemic scleroderma	0.000123	0.000671	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisone—systemic scleroderma	0.000122	0.000665	CcSEcCtD
Tapentadol—Dyspepsia—Methotrexate—systemic scleroderma	0.000122	0.000664	CcSEcCtD
Tapentadol—Decreased appetite—Methotrexate—systemic scleroderma	0.000121	0.000656	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00012	0.000652	CcSEcCtD
Tapentadol—Fatigue—Methotrexate—systemic scleroderma	0.00012	0.000651	CcSEcCtD
Tapentadol—Asthenia—Prednisone—systemic scleroderma	0.000119	0.000648	CcSEcCtD
Tapentadol—Pruritus—Prednisone—systemic scleroderma	0.000117	0.000639	CcSEcCtD
Tapentadol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000114	0.000622	CcSEcCtD
Tapentadol—Diarrhoea—Prednisone—systemic scleroderma	0.000114	0.000618	CcSEcCtD
Tapentadol—Urticaria—Methotrexate—systemic scleroderma	0.00011	0.0006	CcSEcCtD
Tapentadol—Dizziness—Prednisone—systemic scleroderma	0.00011	0.000597	CcSEcCtD
Tapentadol—Vomiting—Prednisone—systemic scleroderma	0.000106	0.000574	CcSEcCtD
Tapentadol—Rash—Prednisone—systemic scleroderma	0.000105	0.000569	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—systemic scleroderma	0.000105	0.000569	CcSEcCtD
Tapentadol—Headache—Prednisone—systemic scleroderma	0.000104	0.000566	CcSEcCtD
Tapentadol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000102	0.000556	CcSEcCtD
Tapentadol—Asthenia—Methotrexate—systemic scleroderma	9.96e-05	0.000542	CcSEcCtD
Tapentadol—Nausea—Prednisone—systemic scleroderma	9.86e-05	0.000536	CcSEcCtD
Tapentadol—Pruritus—Methotrexate—systemic scleroderma	9.82e-05	0.000534	CcSEcCtD
Tapentadol—Diarrhoea—Methotrexate—systemic scleroderma	9.49e-05	0.000516	CcSEcCtD
Tapentadol—Dizziness—Methotrexate—systemic scleroderma	9.18e-05	0.000499	CcSEcCtD
Tapentadol—Vomiting—Methotrexate—systemic scleroderma	8.82e-05	0.00048	CcSEcCtD
Tapentadol—Rash—Methotrexate—systemic scleroderma	8.75e-05	0.000476	CcSEcCtD
Tapentadol—Dermatitis—Methotrexate—systemic scleroderma	8.74e-05	0.000475	CcSEcCtD
Tapentadol—Headache—Methotrexate—systemic scleroderma	8.69e-05	0.000473	CcSEcCtD
Tapentadol—Nausea—Methotrexate—systemic scleroderma	8.24e-05	0.000448	CcSEcCtD
